Codexis applies its platform technology to customize proprietary biocatalysts for bioindustrial applications, including advanced biofuels and carbon capture, as well as in pharmaceutical manufacturing. These biocatalysts are highly efficient "super" enzymes that have been evolved to perform a specific desired catalytic process to a critical set of specifications.

Codexis biocatalysts replace costly high-energy chemical steps with novel biocatalytic reactions, thereby creating and improving chemical processes. These resulting processes are highly efficient, require relatively low energy inputs and generate minimal toxic byproducts. In addition, they eliminate the need for hazardous reagents, and avoid costly and often toxic waste streams.